Find clinical trials for Multiple Sclerosis (MS) in Sevilla, AN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Sclerosis

Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis

Chronic Progressive Multiple Sclerosis

Amyotrophic Lateral Sclerosis

Motor Neuron Disease

Muscle Spasticity

Multiple Sclerosis (MS) trials near Sevilla, AN, ESP:

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis (NEOS)

Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...

Enrolling

Multiple Sclerosis (MS)

Drug: Siponimod

Drug: Ofatumumab

Phase 3

Novartis

Sevilla, Andalucia, Spain and 72 other locations

This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)

This extension study will evaluate the effectiveness and safety of ocrelizumab in multiple sclerosis (MS) participants who...

Active, not recruiting

Multiple Sclerosis

Drug: Ocrelizumab

Phase 3

Roche

Sevilla, Spain and 161 other locations

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...

Enrolling

Multiple Sclerosis

Drug: Placebo capsule

Drug: Fingolimod

Phase 3

Novartis

Sevilla, Andalucia, Spain and 107 other locations

A Study To Evaluate Safety And Efficacy Of Ocrelizumab In Comparison With Fingolimod In Children And Adolescents With Relapsing-Remitting Multiple Sclerosis (Operetta 2)

with fingolimod in children and adolescents with relapsing-remitting multiple sclerosis aged between 10 and < 18 years over a durat...

Enrolling

Relapsing-Remitting Multiple Sclerosis

Other: Ocrelizumab Placebo

Other: Fingolimod Placebo

Phase 3

Roche

Sevilla, Spain and 118 other locations

Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS (STHENOS)

study will compare ofatumumab vs. European approved platform first line self-administered disease modifying therapy (DMT) in newly diagnosed MS...

Enrolling

Multiple Sclerosis

Drug: Ofatumumab

Drug: First line DMT

Phase 3

Novartis

Sevilla, Andalucia, Spain and 49 other locations

An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab (ARTIOS)

Open-label study to evaluate the effectiveness of treatment with ofatumumab in subjects transitioning from any fumarate-based RMS approved therapy or...

Active, not recruiting

Relapsing Multiple Sclerosis

Biological: Ofatumumab

Phase 3

Novartis

Sevilla, Andalucia, Spain and 122 other locations

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...

Enrolling

Relapsing Multiple Sclerosis

Drug: Teriflunomide

Drug: Remibrutinib

Phase 3

Novartis

Sevilla, Andalucia, Spain and 208 other locations

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...

Enrolling

Relapsing Multiple Sclerosis

Drug: Teriflunomide

Drug: Remibrutinib

Phase 3

Novartis

Sevilla, Andalucia, Spain and 225 other locations

Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) (CONNECT)

The primary objective of Part 2 is to evaluate the long-term safety of BG00012 in subjects who completed Week 96 in Part 1 of Study 109MS306...

Active, not recruiting

Relapsing-Remitting Multiple Sclerosis

Drug: dimethyl fumarate

Drug: Interferon β-1a

Phase 3

Biogen

Sevilla, Spain and 61 other locations

A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis (Ocarina II)

(IV) infusion of ocrelizumab in patients with either relapsing multiple sclerosis (RMS) or primary progressive multiple sc...

Active, not recruiting

Primary Progressive Multiple Sclerosis

Relapsing Multiple Sclerosis

Drug: Methylprednisolone IV

Drug: Ocrelizumab SC

Phase 3

Roche

Seville, Sevilla, Spain and 37 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Multiple Sclerosis (MS) in .css-epvm6{white-space:nowrap;}Sevilla, AN

Related conditions:

Multiple Sclerosis (MS) trials near Sevilla, AN, ESP:

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis (NEOS)

This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

A Study To Evaluate Safety And Efficacy Of Ocrelizumab In Comparison With Fingolimod In Children And Adolescents With Relapsing-Remitting Multiple Sclerosis (Operetta 2)

Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS (STHENOS)

An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab (ARTIOS)

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)

Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) (CONNECT)

A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis (Ocarina II)

Find clinical trials for Multiple Sclerosis (MS) in Sevilla, AN